{"id":"W2276391444","doi":"10.1093/neuonc/nov300","title":"Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Bevacizumab; Temozolomide; Medicine; Placebo; Radiation therapy; Adverse effect; Surgery; Internal medicine; Oncology; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001002257,0.0003095708,0.0006743757,0.0001560404,0.0001553467,0.0000174942,0.00006310136,0.0002068867,0.0000461871],"category_scores_gemma":[0.0001756639,0.0001978576,0.0001107079,0.0001016282,0.000217005,0.00008331156,0.00005321693,0.0001130207,0.000006176732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001934368,"about_ca_system_score_gemma":0.00006499029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001520603,"about_ca_topic_score_gemma":0.0001490167,"domain_scores_codex":[0.9982789,0.0001007107,0.0004393812,0.0006345006,0.0001328812,0.0004136465],"domain_scores_gemma":[0.9968228,0.002306653,0.0001580406,0.0003383453,0.0001233433,0.0002508257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0816634,0.001554129,0.05825385,0.0001424963,0.0005170588,0.002441989,0.001183903,0.000007255536,0.5097523,0.00007471465,0.003812097,0.3405968],"study_design_scores_gemma":[0.1283416,0.01501466,0.4061164,0.00015851,0.0001623312,0.0008553669,0.00005873604,0.00006961584,0.05533941,0.00009625755,0.3934206,0.0003664843],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726939,0.003553351,0.00004745394,0.02159509,0.0002519627,0.001582242,0.0001355119,0.00007438401,0.00006608292],"genre_scores_gemma":[0.9797961,0.01618675,0.000633159,0.002477189,0.0003261422,0.0004741705,0.000009480846,0.00005697736,0.00004010416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4544129,"threshold_uncertainty_score":0.8068401,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01716518308352756,"score_gpt":0.2854753499610148,"score_spread":0.2683101668774872,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}